Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile Carroll Shelby International Inc CSBI

Consumer Cyclical Auto Manufacturers
Carroll Shelby International Inc is engaged in the manufacturing and marketing of performance vehicles and related accessories. It offers authentic continuation Cobras, including the Cobra 427 S/C, the Cobra 289 FIA and the Cobra 289 S/C which are sold as component vehicles. In addition, it licenses Shelby brand to third parties in connection with various products, such as vehicles, memorabilia... see more

Showcase News Releases

Showcase news

Falcon Gold Corp.
Falcon Commences Drilling At Its Great Burnt Copper Project, NL
Geologica Resource Corp.
Geologica Acquires 100% of Lincoln Claims Developing District Play in Prolific Atlin Mining District
Revive Therapeutics Ltd
Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures

More Showcase News Releases »